MedTrace Logo

Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity

NCT01456845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2012-08-31

No results posted yet for this study

Summary

The purpose of the study is to estimate plasma drug levels ( free and total drug levels ) of rifampicin and other antituberculosis drugs and compare these drug levels in patients who develop drug induced hepatotoxicity versus those who do not .The study hypothesis is that the ATT drug induced hepatotoxicity is related to free drug levels of rifampicin and other antituberculosis drugs .

Conditions

Sponsors & Collaborators

  • All India Institute of Medical Sciences

    lead OTHER

Principal Investigators

  • Surendra K Sharma, MD,Ph.D · All India Institute of Medical Sciences, New Delhi-110029, India

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01456845 on ClinicalTrials.gov